120 results
424B5
IMNM
Immunome, Inc.
14 May 24
Prospectus supplement for primary offering
8:48am
materials, as the case may be.
Any agents and underwriter may engage in overallotment, stabilizing transactions, short covering transactions
DEFA14A
bls5b3p6zrvyyi2i
26 Apr 24
Additional proxy soliciting materials
4:08pm
8-K
EX-10.1
2k46cmnui91cl1g
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am